Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult Subjects

ClinicalTrials.gov ID: NCT04196101

Public ClinicalTrials.gov record NCT04196101. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of EDP-938 Administered Orally for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Ambulatory Adult Subjects (RSVP)

Study identification

NCT ID
NCT04196101
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Enanta Pharmaceuticals, Inc
Industry
Enrollment
82 participants

Conditions and interventions

Interventions

  • EDP-938 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 21, 2020
Primary completion
Jan 3, 2022
Completion
Jan 3, 2022
Last update posted
Oct 29, 2023

2020 – 2022

United States locations

U.S. sites
12
U.S. states
7
U.S. cities
12
Facility City State ZIP Site status
Central Alabama Research Birmingham Alabama 35209
Cahaba Research Inc. - Birmingham Pelham Alabama 35124
Saint Joseph's Clinical Research Anaheim California 92804
Torrance Clinical Research Institute Lomita California 90717
Miami Clinical Research - ClinEdge - PPDS Miami Florida 33155
Pioneer Clinical Research LLC Bellevue Nebraska 68005
Meridian Clinical Research Norfolk Nebraska 68701
Clinical Research of South Nevada Las Vegas Nevada 89121
Carolina Research Center Shelby North Carolina 28150
PMG Research of Wilmington Wilmington North Carolina 28401
Progressive Medicine of the Triad, LLC Winston-Salem North Carolina 27103
FMC Science Lampasas Texas 76550

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04196101, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 29, 2023 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04196101 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →